FDA recall D-0434-2024

X-Gen Pharmaceuticals Inc. · Class III · drug

Product

Cyclophosphamide for Injection, USP, 1g/vial, Lyophilized, Single Dose Vial, Discard unused solution, Cytotoxic Agent, After Reconstitution: For direct intravenous injection or must be further diluted before intravenous infusion, Rx Only, Manufactured for: XGen Pharmaceuticals DJB, Inc., Big Flats, NY 14814, NDC # 39822-0255-01.

Reason for recall

Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of the reconstituted product is listed as '20 mg per vial.' This information should read: '20 mg per mL'.

Distribution

Nationwide in the US

Key facts

Status
Terminated
Initiation date
2024-04-02
Report date
2024-04-10
Termination date
2025-09-30
Voluntary/Mandated
Voluntary: Firm initiated
Location
Horseheads, NY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0434-2024